Premium
Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory H odgkin lymphoma
Author(s) -
Dozzo Massimo,
Zaja Francesco,
Volpetti Stefano,
Sperotto Alessandra,
Magli Alessandro,
Fanin Renato
Publication year - 2015
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.23925
Subject(s) - medicine , brentuximab vedotin , oncology , gastroenterology , chemotherapy , refractory (planetary science) , radiation therapy , surgery , lymphoma , cd30 , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom